You are here: Industry Insights > Brain Tumors

News List

Treovir Announces Opening of G207 Phase 2 Clinical Trial in Children with Recurrent Brain Tumors Biotech Newswire
December 05, 2024
Treovir, Inc. announced today the opening of a Phase 2 trial testing G207, an oncolytic HSV immunotherapy, in pediatric brain tumor patients.
Targeted drug combination shows unprecedented activity in some highly aggressive brain tumors WorldPharmaNews
November 26, 2021
A combination of two targeted cancer drugs showed unprecedented, "clinically meaningful" activity in patients with highly malignant brain tumors that carried a rare genetic mutation...
NaviFUS begins FUS combined with radiotherapy clinical trial for the treatment of terminal primary brain tumors prnasia
August 04, 2021
NaviFUS' focused ultrasound (FUS) therapy system (NaviFUS®) was recently approved for use in a new clinical trial by the Taiwan, China Food and Drug Administration (TFDA).
DelMar Updates Clinical Trial of VAL-083 for Adjuvant Treatment of Brain Tumors americanpharmaceuticalreview
May 07, 2020
DelMar Pharmaceuticals has enrolled 22 patients in the adjuvant arm of the Company's ongoing Phase 2 clinical study investigating adjuvant treatment (pre-temozolomide -- or TMZ -- maintenance therapy) of MGMT-unmethylated glioblastoma multiforme (GBM) ...
Laser-Based Imaging + AI May Diagnose Brain Tumors in OR drugs
January 07, 2020
A novel workflow that combines advanced optical imaging with an artificial intelligence algorithm may accurately diagnose brain tumors in real time in the operating room, according to a study published online Jan. 6 in Nature Medicine.
New Treatments Could Be Powerful Weapons Against Brain Tumors drugs
August 15, 2019
New therapies are showing real promise in fighting the type of brain cancer that claimed the lives of Sens. John McCain and Ted Kennedy, a pair of new clinical trials shows.